Guardant Health Inc (GH)
18.88
+0.30
(+1.61%)
USD |
NASDAQ |
May 03, 16:00
18.90
+0.02
(+0.13%)
After-Hours: 20:00
Guardant Health Cash from Operations (Quarterly): -78.73M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -78.73M |
| September 30, 2023 | -77.79M |
| June 30, 2023 | -94.02M |
| March 31, 2023 | -74.44M |
| December 31, 2022 | -90.75M |
| September 30, 2022 | -78.16M |
| June 30, 2022 | -111.94M |
| March 31, 2022 | -28.62M |
| December 31, 2021 | -76.99M |
| September 30, 2021 | -53.14M |
| June 30, 2021 | -62.59M |
| March 31, 2021 | -16.29M |
| Date | Value |
|---|---|
| December 31, 2020 | -59.22M |
| September 30, 2020 | -8.057M |
| June 30, 2020 | -23.36M |
| March 31, 2020 | -13.28M |
| December 31, 2019 | -30.34M |
| September 30, 2019 | 1.347M |
| June 30, 2019 | -13.84M |
| March 31, 2019 | -4.303M |
| December 31, 2018 | -26.54M |
| September 30, 2018 | -22.05M |
| June 30, 2018 | -17.04M |
| March 31, 2018 | -6.559M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-111.94M
Minimum
Jun 2022
1.347M
Maximum
Sep 2019
-52.12M
Average
-59.22M
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| Exact Sciences Corp | 69.55M |
| Illumina Inc | 224.00M |
| Delcath Systems Inc | -8.178M |
| CytoSorbents Corp | -6.407M |
| Progyny Inc | 37.66M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 663.45M |
| Cash from Financing (Quarterly) | 90.57M |
| Free Cash Flow | -345.46M |
| Free Cash Flow Per Share (Quarterly) | -0.6983 |
| Free Cash Flow to Equity (Quarterly) | -83.45M |
| Free Cash Flow to Firm (Quarterly) | -82.80M |
| Free Cash Flow Yield | -16.35% |